For this purpose, tumor-specific CD4 and CD8 T cells were shown to increase their effector functions to slow tumor growth by increasing PEP production through the over-expression of phosphoenolpyruvate carboxykinase 1 (PCK1) [111]. This evidence concerns the gene CD4 and neoplasm.